Robert Garber
Managing Partner @ 7wire Ventures
Chicago, United States
Robert Garber is a Series A investor at 7wire Ventures in Chicago focused on Health Care and Wellness. Robert Garber is based out of Chicago, Illinois and is the Managing Partner of 7wire Ventures. Robert previously worked at RecoveryOne as a Board Member. Robert Garber attended the Northwestern University - Kellogg School of Management.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries Robert Garber invests in
Health CareWellnessMedicalMedical DeviceFinTech
Stages Robert Garber invests in
Series ASeries BSeries CVenture - Series Unknown
Countries Robert Garber invests in
United States
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (46%)
- Wellness 3 (23%)
- Medical 2 (15%)
- Medical Device 2 (15%)
- FinTech 1 (8%)
Stage
- Series A 5 (38%)
- Series B 5 (38%)
- Series C 2 (15%)
- Venture - Series Unknown 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
When Insurance
|
When Insurance is a technology platform that helps individuals and employers navigate health insurance options during transitions such as job loss or retirement. It connects users with a marketplace of health plans from third-party providers and offers tools to compare and apply for coverage alternatives to COBRA, including personalized guidanceand reimbursement options for premiums. The platform integrates with HR systems to support workforce offboarding, provides concierge support from licensed advisors, and assists with Medicare navigation and healthcare reimbursement benefits. When Insurance operates as an intermediary facilitating access to health insurance choices rather than selling insurance directly. | $10.2M / Series A / Jan 30, 2026 | |
GroundGame Health
|
GroundGame Health provides care delivery including SDOH for economically disadvantaged populations and communities. | $17M / Series A / Apr 30, 2024 | |
Vivante Health
|
Since 2016, Vivante Health has been revolutionizing digestive health and wellness, one person at a time. Our category-defining digital health solutions provide personalized, comprehensive care for people with digestive conditions. Our all-in-one digestive health program GIThrive® combines clinically-backed interactive tech, targeted nutrition, and24/7 personal support to improve digestive disease outcomes, and reduce the cost of care. GIThrive is used by large employers and health plans to reduce the costs of chronic disease, improve employee health, and workplace absenteeism. | $31M / Series B / Sep 20, 2023 | |
Cylinder
|
Founded in 2021 and offered as an employer benefit, Cylinder (formerly Vivante Health) delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform. Cylinder’s tech-forward, human-first program connects members to the right level of support at the right time through an easy interface,bringing the healthcare ecosystem together to align around member needs. Cylinder’s dedicated care teams help members proactively address their gut health from every angle – decreasing costs, reducing absenteeism, and improving their quality of life, at scale. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive healthcare they need to improve their overall health. Learn more at cylinderhealth.com. | $31M / Series B / Sep 20, 2023 | |
|
Vivante Health
|
Since 2016, Vivante Health has been revolutionizing digestive health and wellness, one person at a time. Our category-defining digital health solutions provide personalized, comprehensive care for people with digestive conditions. Our all-in-one digestive health program GIThrive® combines clinically-backed interactive tech, targeted nutrition, and24/7 personal support to improve digestive disease outcomes, and reduce the cost of care. GIThrive is used by large employers and health plans to reduce the costs of chronic disease, improve employee health, and workplace absenteeism. | $16M / Series A / Mar 08, 2022 | |
|
Cylinder
|
Founded in 2021 and offered as an employer benefit, Cylinder (formerly Vivante Health) delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform. Cylinder’s tech-forward, human-first program connects members to the right level of support at the right time through an easy interface,bringing the healthcare ecosystem together to align around member needs. Cylinder’s dedicated care teams help members proactively address their gut health from every angle – decreasing costs, reducing absenteeism, and improving their quality of life, at scale. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive healthcare they need to improve their overall health. Learn more at cylinderhealth.com. | $16M / Series A / Mar 08, 2022 | |
Zerigo Health
|
Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions.Clarify Medicalindicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction. | $43M / Series B / Oct 21, 2021 | |
RecoveryOne
|
RecoveryOne is an innovator in mHealth solutions for patients recovering from orthopedic injuries. The company provides personalized programs that combine digital therapy and live coaching to reduce costs, accelerate recovery, and drive patient satisfaction. RecoveryOne was founded in 2014 and is headquartered in Walnut Creek, California. | $33M / Series C / Sep 08, 2021 | |
|
RecoveryOne
|
RecoveryOne is an innovator in mHealth solutions for patients recovering from orthopedic injuries. The company provides personalized programs that combine digital therapy and live coaching to reduce costs, accelerate recovery, and drive patient satisfaction. RecoveryOne was founded in 2014 and is headquartered in Walnut Creek, California. | $12M / Venture - Series Unknown / Dec 17, 2019 | |
|
Zerigo Health
|
Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions.Clarify Medicalindicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction. | $18M / Series A / Oct 23, 2019 | |
| See all 13 investments → | |||
Co-Investors
About 7wire Ventures
7wire ventures focuses on investing in early and growth-stage companies focused on healthcare IT, digital healtcare and mobile health.
7wire Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lee Shapiro
Co-Founder & Managing Partner
|
|||
|
Robert Garber
Managing Partner
|
|||
Alyssa Jaffee
Partner
|
|||
David Schonthal
Operating Partner
|
|||
Glen Tullman
Co-Founder & Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FinTech Investors
47,630 investors
Health Care Investors
47,147 investors
Medical Investors
20,530 investors
Wellness Investors
12,662 investors
Medical Device Investors
12,078 investors
FinTech VC Funds
31,727 investors
Health Care VC Funds
35,356 investors
Medical VC Funds
17,653 investors
Wellness VC Funds
9,059 investors
FAQ
What does Robert Garber invest in?
Robert Garber invests primarily in Health Care, Wellness and Medical startups, most often at Series A and Series B stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Robert Garber?
Public channels for Robert Garber include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Robert Garber last invest?
The most recent investment recorded for Robert Garber closed in Jan 2026. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
